UK markets closed

Original BioMedicals Co., Ltd. (6483.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
16.000.00 (0.00%)
At close: 02:59PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 1.03B
Enterprise value 717.34M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)18.29k
Price/book (mrq)3.13
Enterprise value/revenue 16.68k
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -0.00
52-week change 3-7.27%
S&P500 52-week change 326.36%
52-week high 328.00
52-week low 314.60
50-day moving average 316.70
200-day moving average 316.70

Share statistics

Avg vol (3-month) 3610.07k
Avg vol (10-day) 3290.55k
Shares outstanding 564.55M
Implied shares outstanding 665.97M
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-86,206.98%

Management effectiveness

Return on assets (ttm)-15.81%
Return on equity (ttm)-30.00%

Income statement

Revenue (ttm)43k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-59.80%
Gross profit (ttm)N/A
EBITDA -54.64M
Net income avi to common (ttm)-59.66M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)328.48M
Total cash per share (mrq)5.01
Total debt (mrq)16.24M
Total debt/equity (mrq)4.94%
Current ratio (mrq)12.26
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-29.5M
Levered free cash flow (ttm)-7.75M